BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11526102)

  • 1. Kinetic analysis of the conjugation of ubiquitin to picornavirus 3C proteases catalyzed by the mammalian ubiquitin-protein ligase E3alpha.
    Lawson TG; Sweep ME; Schlax PE; Bohnsack RN; Haas AL
    J Biol Chem; 2001 Oct; 276(43):39629-37. PubMed ID: 11526102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of a protein destruction signal in the encephalomyocarditis virus 3C protease.
    Lawson TG; Gronros DL; Evans PE; Bastien MC; Michalewich KM; Clark JK; Edmonds JH; Graber KH; Werner JA; Lurvey BA; Cate JM
    J Biol Chem; 1999 Apr; 274(14):9871-80. PubMed ID: 10092679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation of the encephalomyocarditis virus and hepatitis A virus 3C proteases by the ubiquitin/26S proteasome system in vivo.
    Schlax PE; Zhang J; Lewis E; Planchart A; Lawson TG
    Virology; 2007 Apr; 360(2):350-63. PubMed ID: 17150238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signals in hepatitis A virus P3 region proteins recognized by the ubiquitin-mediated proteolytic system.
    Losick VP; Schlax PE; Emmons RA; Lawson TG
    Virology; 2003 May; 309(2):306-19. PubMed ID: 12758177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-end rule specificity within the ubiquitin/proteasome pathway is not an affinity effect.
    Baboshina OV; Crinelli R; Siepmann TJ; Haas AL
    J Biol Chem; 2001 Oct; 276(42):39428-37. PubMed ID: 11493606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the susceptibility of the 3C proteases of hepatitis A virus and poliovirus to degradation by the ubiquitin-mediated proteolytic system.
    Gladding RL; Haas AL; Gronros DL; Lawson TG
    Biochem Biophys Res Commun; 1997 Sep; 238(1):119-25. PubMed ID: 9299463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E6AP/UBE3A catalyzes encephalomyocarditis virus 3C protease polyubiquitylation and promotes its concentration reduction in virus-infected cells.
    Carmody M; Notarianni TP; Sambel LA; Walsh SJ; Burke JM; Armstrong JL; Lawson TG
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):63-69. PubMed ID: 29054411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The encephalomyocarditis virus 3C protease is a substrate for the ubiquitin-mediated proteolytic system.
    Lawson TG; Gronros DL; Werner JA; Wey AC; DiGeorge AM; Lockhart JL; Wilson JW; Wintrode PL
    J Biol Chem; 1994 Nov; 269(45):28429-35. PubMed ID: 7961784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of a protein destruction signal in the encephalomyocarditis virus 3C protease.
    Lawson TG; Gronros DL; Evans PE; Bastien MC; Michalewich KM; Clark JK; Edmonds JH; Graber KH; Werner JA; Lurvey BA; Cate JM
    J Biol Chem; 1999 Apr; 274(14):9904-80. PubMed ID: 10092683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein interactions within the N-end rule ubiquitin ligation pathway.
    Siepmann TJ; Bohnsack RN; Tokgöz Z; Baboshina OV; Haas AL
    J Biol Chem; 2003 Mar; 278(11):9448-57. PubMed ID: 12524449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIM22 E3 ubiquitin ligase activity is required to mediate antiviral activity against encephalomyocarditis virus.
    Eldin P; Papon L; Oteiza A; Brocchi E; Lawson TG; Mechti N
    J Gen Virol; 2009 Mar; 90(Pt 3):536-545. PubMed ID: 19218198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protease 3C of hepatitis A virus induces vacuolization of lysosomal/endosomal organelles and caspase-independent cell death.
    Shubin AV; Demidyuk IV; Lunina NA; Komissarov AA; Roschina MP; Leonova OG; Kostrov SV
    BMC Cell Biol; 2015 Feb; 16():4. PubMed ID: 25886889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Encephalomyocarditis Virus 3C Protease Relieves TRAF Family Member-associated NF-κB Activator (TANK) Inhibitory Effect on TRAF6-mediated NF-κB Signaling through Cleavage of TANK.
    Huang L; Liu Q; Zhang L; Zhang Q; Hu L; Li C; Wang S; Li J; Zhang Y; Yu H; Wang Y; Zhong Z; Xiong T; Xia X; Wang X; Yu L; Deng G; Cai X; Cui S; Weng C
    J Biol Chem; 2015 Nov; 290(46):27618-32. PubMed ID: 26363073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis A virus proteinase 3C binding to viral RNA: correlation with substrate binding and enzyme dimerization.
    Peters H; Kusov YY; Meyer S; Benie AJ; Bäuml E; Wolff M; Rademacher C; Peters T; Gauss-Müller V
    Biochem J; 2005 Jan; 385(Pt 2):363-70. PubMed ID: 15361063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of active-site amino acid residues in the Chiba virus 3C-like protease.
    Someya Y; Takeda N; Miyamura T
    J Virol; 2002 Jun; 76(12):5949-58. PubMed ID: 12021327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential temperature dependence of tobacco etch virus and rhinovirus 3C proteases.
    Raran-Kurussi S; Tözsér J; Cherry S; Tropea JE; Waugh DS
    Anal Biochem; 2013 May; 436(2):142-4. PubMed ID: 23395976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of protein catabolism by muscle-specific and cytokine-inducible ubiquitin ligase E3alpha-II during cancer cachexia.
    Kwak KS; Zhou X; Solomon V; Baracos VE; Davis J; Bannon AW; Boyle WJ; Lacey DL; Han HQ
    Cancer Res; 2004 Nov; 64(22):8193-8. PubMed ID: 15548684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Encephalomyocarditis virus 3C protease attenuates type I interferon production through disrupting the TANK-TBK1-IKKε-IRF3 complex.
    Huang L; Xiong T; Yu H; Zhang Q; Zhang K; Li C; Hu L; Zhang Y; Zhang L; Liu Q; Wang S; He X; Bu Z; Cai X; Cui S; Li J; Weng C
    Biochem J; 2017 Jun; 474(12):2051-2065. PubMed ID: 28487378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The encephalomyocarditis virus 3C protease is rapidly degraded by an ATP-dependent proteolytic system in reticulocyte lysate.
    Oberst MD; Gollan TJ; Gupta M; Peura SR; Zydlewski JD; Sudarsanan P; Lawson TG
    Virology; 1993 Mar; 193(1):28-40. PubMed ID: 8382397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward development of generic inhibitors against the 3C proteases of picornaviruses.
    Banerjee K; Bhat R; Rao VUB; Nain A; Rallapalli KL; Gangopadhyay S; Singh RP; Banerjee M; Jayaram B
    FEBS J; 2019 Feb; 286(4):765-787. PubMed ID: 30461192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.